Studies in Taiwan have shown a 2.28-fold increase in the risk of tuberculosis in patients with rheumatoid arthritis than that in the general population (Liao et al., 2015), while patients treated with TNF-α inhibitors were at higher risk of developing tuberculosis than those treated with other medications (Lim et al., 2016). This evidence concerns the gene TNF and tuberculosis.